HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
Home » News » ICER Publishes Draft Scoping Doc on CAR-T Therapies

ICER Publishes Draft Scoping Doc on CAR-T Therapies

The Institute for Clinical and Economic Review (ICER) on Wednesday posted a Draft Scoping Document on chimeric antigen receptor t-cell (CAR-T) therapies.

According to a press release issued by ICER, the institute will accept public comments until a 5 p.m. EST Aug. 29 deadline.

ICER says it will focus on clinical effectiveness and value research of CAR-T therapies during a California Technology Assessment Forum (CTAF) meeting in March.

“The Draft Scoping Document was developed with input from key stakeholders, including patients and patient advocacy groups, who provided important insights into the context of treatment decisions,” ICER says in a statement. “Of note, patients expressed hope that CAR-T therapy would offer improved survival and better quality of life compared to other treatments they had tried.”

A revised scoping document will be published in September after the public comment deadline passes.

Click here to read the full press release on ICER’s website.

The Draft Scoping Document can be read here.



You might also be interested in:

  • Amalgam Rx™ and AWS Collaborate to Accelerate and Simplify… 07/19/2021
  • OM1 Launches Real-World Data Network for Neuroscience and… 03/31/2022
  • Parexel and Kyoto University Hospital Announce Strategic… 10/28/2021
  • Webinar: Strategies to Overcome CAR-T Cell Resistance During… 01/07/2022
  • Study: Asian-American Health Impacted by Stereotypes and Poor Data 03/17/2022
  • ICER Meets With FDA, EMA, and FDA to Discuss RWE Procedures 10/12/2021
  • Costly Oncology Drugs Face ICER Scrutiny and Calls for… 08/03/2021

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Manager/Manager, RWE
  • Biostatistician/Statistical Analyst
  • Manager - Real World Evidence Engagement Lead (Remote- US)
  • Associate Director, Value & Access Strategy (Remote)
  • Manager, Value and Access Strategy (Remote- US)
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts